Columbus Copper Acquires Dinaric to Acquire Pending Onshore Hydrocarbon Licence Block 8 in Albania

Columbus Copper Corporation ("Columbus Copper") announces that it has entered into an agreement (the "Agreement") pursuant to which it will acquire the rights to pending onshore hydrocarbon licence Block 8 (the "Licence") in Albania through the acquisition of BVI-incorporated Dinaric International Energy Corporation and its Albanian subsidiary, Albanides Energy Sh.p.k.

Albania is a significant onshore oil producer in Europe and Block 8 is one of the largest exploration licences in that country. Following is a link indicating the location of Block 8:

www.columbuscopper.com/i/nr/2015-03-06-map.pdf

Under the Agreement, the shares of Dinaric will be transferred to Columbus Copper or its designated affiliate as soon as practicable. Upon formal granting of the Licence to Albanides, Columbus Copper will pay to the majority shareholder of Dinaric ("Antares") $90,000 and will issue to the shareholders of Dinaric (the "Vendors") and to shareholders of Antares a total of 9,300,000 of its common shares such that no individual or entity will receive more than 9.9% of the post-transaction issued and outstanding common shares of Columbus Copper. In the event that the Licence is not granted to Albanides by June 1, 2015 (unless otherwise agreed to by the parties), Columbus Copper will, at the election of the Vendors, either dissolve Dinaric and Albanides or return the shares of Dinaric to the Vendors. For clarity, no cash will be paid and no shares will be issued by Columbus Copper until the Licence has been granted to Albanides.

The Agreement and related transactions are subject to the approval of the TSX Venture Exchange.

ON BEHALF OF THE BOARD

David Cliff, President & CEO

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.